- Home
- IVDA vs ADTX Comparison
IVDA vs ADTX Comparison
Compare IVDA & ADTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IVDA
- ADTX
- Stock Information
- Founded
- IVDA 2003
- ADTX 2017
- Country
- IVDA United States
- ADTX United States
- Employees
- IVDA N/A
- ADTX N/A
- Industry
- IVDA Computer Software: Prepackaged Software
- ADTX Biotechnology: Pharmaceutical Preparations
- Sector
- IVDA Technology
- ADTX Health Care
- Exchange
- IVDA Nasdaq
- ADTX Nasdaq
- Market Cap
- IVDA 4.3M
- ADTX 4.9M
- IPO Year
- IVDA N/A
- ADTX 2020
- Fundamental
- Price
- IVDA $1.47
- ADTX $1.03
- Analyst Decision
- IVDA
- ADTX
- Analyst Count
- IVDA 0
- ADTX 0
- Target Price
- IVDA N/A
- ADTX N/A
- AVG Volume (30 Days)
- IVDA 268.2K
- ADTX 188.8K
- Earning Date
- IVDA 11-13-2025
- ADTX 08-14-2025
- Dividend Yield
- IVDA N/A
- ADTX N/A
- EPS Growth
- IVDA N/A
- ADTX N/A
- EPS
- IVDA N/A
- ADTX N/A
- Revenue
- IVDA $7,142,302.00
- ADTX $12,051.00
- Revenue This Year
- IVDA $340.48
- ADTX $15,768.94
- Revenue Next Year
- IVDA N/A
- ADTX N/A
- P/E Ratio
- IVDA N/A
- ADTX N/A
- Revenue Growth
- IVDA 88.96
- ADTX N/A
- 52 Week Low
- IVDA $1.27
- ADTX $0.81
- 52 Week High
- IVDA $8.05
- ADTX $4,900.00
- Technical
- Relative Strength Index (RSI)
- IVDA 51.14
- ADTX 48.40
- Support Level
- IVDA $1.36
- ADTX $0.98
- Resistance Level
- IVDA $1.62
- ADTX $1.11
- Average True Range (ATR)
- IVDA 0.10
- ADTX 0.07
- MACD
- IVDA -0.07
- ADTX 0.01
- Stochastic Oscillator
- IVDA 88.69
- ADTX 61.19
About IVDA Iveda Solutions Inc.
Iveda Solutions Inc offers smart city technologies globally, offering advanced AI-driven video surveillance solutions and a robust suite of Internet of Things (IoT) platforms that power digital transformation for cities and commercial clients worldwide. The smart cities market, as well as the AI and IoT segments, are poised for significant growth in the coming years. The company offers AI-intelligent video search, smart utility, smart sensors, gateways, and trackers, and IoT platforms (Products).
About ADTX Aditxt Inc.
Aditxt Inc is a life sciences company that develops, builds, and grows innovations with a focus on monitoring and modulating the immune system. It develops products designed to induce tolerance to transplanted organs. Its portfolio consists of two programs Adimune and AditxtScore. It firm's immunosuppressive (anti-rejection) drugs have made possible life-saving organ transplantation procedures and blocking of unwanted immune responses in autoimmune diseases. It is also developing a technology called Apoptotic DNA Immunotherapy (ADi) ADI-100, which utilizes a novel approach that mimics, the way bodies naturally induce tolerance to tissues.